VOR · Company research
Vor Biopharma Inc. (VOR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
22records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| VOR May 2027 12.500 call (VOR270521C00012500) Stock Price, News, Quote & History - Yahoo! Finance Canada | VOR May 2027 12.500 call (VOR270521C00012500) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 19, 2026 | neutral | 0 | 0.6 |
| TOL,THFF,SOC,ACI,VOR,VIRC,KWY | Stock Prices | Quote Comparison - Yahoo! Finance Canada | TOL,THFF,SOC,ACI,VOR,VIRC,KWY | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 19, 2026 | neutral | 0 | 0.6 |
| Discipline and Rules-Based Execution in VOR Response - Stock Traders Daily | Discipline and Rules-Based Execution in VOR Response Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 19, 2026 | neutral | 0 | 0.6 |
| VOR May 2027 30.000 put (VOR270521P00030000) Interactive Stock Chart - Yahoo! Finance Canada | VOR May 2027 30.000 put (VOR270521P00030000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| VOR Feb 2027 22.500 call (VOR270219C00022500) Interactive Stock Chart - Yahoo! Finance Canada | VOR Feb 2027 22.500 call (VOR270219C00022500) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 18, 2026 | neutral | 0 | 0.6 |
| VOR Feb 2027 30.000 call (VOR270219C00030000) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance Canada | VOR Feb 2027 30.000 call (VOR270219C00030000) Interactive Stock Chart - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| VOR Feb 2027 30.000 call (VOR270219C00030000) Stock Price, News, Quote & History - Yahoo! Finance Canada | VOR Feb 2027 30.000 call (VOR270219C00030000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| Vor Biopharma Stock Price Forecast. Should You Buy VOR? - StockInvest.us | Vor Biopharma Stock Price Forecast. Should You Buy VOR? StockInvest.us | View source ↗ | StockInvest.us | Oct 16, 2026 | neutral | 0 | 0.6 |
| VOR Feb 2027 22.500 call (VOR270219C00022500) Stock Historical Prices & Data - Yahoo Finance - Yahoo! Finance Canada | VOR Feb 2027 22.500 call (VOR270219C00022500) Stock Historical Prices & Data - Yahoo Finance Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 13, 2026 | neutral | 0 | 0.6 |
| VOR May 2027 15.000 put (VOR270521P00015000) Stock Price, News, Quote & History - Yahoo! Finance Canada | VOR May 2027 15.000 put (VOR270521P00015000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 11, 2026 | neutral | 0 | 0.6 |
| Vor Biopharma Inc. (VOR) stock price, news, quote and history - Yahoo Finance UK | Vor Biopharma Inc. (VOR) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 9, 2026 | neutral | 0 | 0.6 |
| Vor Biopharma (VOR) Short Interest & Short Float | Updated Oct 2026 $VOR - MarketBeat | Vor Biopharma (VOR) Short Interest & Short Float | Updated Oct 2026 $VOR MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (VOR) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (VOR) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Vor Bio announced the grant of stock options for 59,250 shares and RSUs for 12,550 shares to 9 newly hired employees on October 1, 2026, as material inducements to employment. The options have a 10-year term with an exercise price of $18.06 per share and vest over four years. The company continues advancing telitacicept through Phase 3 clinical development for autoimmune diseases, with enrollment completed in the UPSTREAM MG trial and expansion into ocular myasthenia gravis. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Vor Bio announced the grant of stock options for 59,250 shares and RSUs for 12,550 shares to 9 newly hired employees on October 1, 2026, as material inducements to employment. The options have a 10-year term with an exercise price of $18.06 per share and vest over four years. The company continues advancing telitacicept through Phase 3 clinical development for autoimmune diseases, with enrollment completed in the UPSTREAM MG trial and expansion into ocular myasthenia gravis. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire | Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire | View source ↗ | GlobeNewswire | Oct 5, 2026 | neutral | 0 | 0.6 |
| Long Lasting Symptom Relief Data Could Be A Game Changer For Vor Biopharma Stock - Webull | Long Lasting Symptom Relief Data Could Be A Game Changer For Vor Biopharma Stock Webull | View source ↗ | Webull | Oct 5, 2026 | neutral | 0 | 0.6 |
| Over 94% of participants improved at least five points on a daily-activity score by week 48 - Stock Titan | Over 94% of participants improved at least five points on a daily-activity score by week 48 Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| A new trial for eye-related muscle weakness is planned for 2027. Vor Bio finished enrolling another. - Stock Titan | A new trial for eye-related muscle weakness is planned for 2027. Vor Bio finished enrolling another. Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| Vor Biopharma (VOR) Stock Looks Reasonable On Earnings Yet Weak On Broader Checks - Simply Wall Street | Vor Biopharma (VOR) Stock Looks Reasonable On Earnings Yet Weak On Broader Checks Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Vor Bio adds Verona Pharma veteran David Zaccardelli to board - Stock Titan | Vor Bio adds Verona Pharma veteran David Zaccardelli to board Stock Titan | View source ↗ | Stock Titan | Jul 7, 2026 | neutral | 0 | 0.6 |
| VOR Forecast — Price Target — Prediction for 2027 - TradingView | VOR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.